Idiosyncratic adverse drug reactions and renin

The two topics are only linked by the fact that they both have been on my mind this week. Novartis recently received approval to market a renin inhibitor…a major accomplishment if you are familiar with this target. I am in the process of writing up a small piece on this…expect it soon.

I am playing with the idea of using “idiosynsyncratic”, as in idiosyncratic drug reactions, as the word of the week. I realize it is a topic that most of us have become very familiar with over the last few years. It is really just a chance to add my two cents to the discussion concerning this issue.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: